AACR 2022 | Liquid biopsies for the detection of precancerous lesions

Nickolas Papadopoulos • 11 Apr 2022

AACR 2022

Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, talks on whether liquid biopsies could be used for the detection of precancerous lesions and discusses how to avoid overdiagnosis when dealing with precancerous lesions. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

Disclosures

Consultant for: Exact Sciences, CAGE Pharma, ManaTbio, NeoPhore, Vidium, Haystack Inc

Stockholder in: Exact Sciences, CAGE Pharma, ManaTbio, NeoPhore, Haystack Inc.

My additional financial relationship disclosures are: BOD – Haystack Inc. PAST: PGDx, Thrive

Sysmex, PGDx, Thrive, ThermoFisher, Exact and other companies have licensed technologies from Johns Hopkins University, on which NP is an inventor. These licenses and relationships are associated with royalty payments to NP. The terms of these arrangements are being managed by Johns Hopkins University in accordance with its conflict of interest policies.